Summit Securities Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,000
Closed -$1.68M 931
2024
Q2
$1.68M Hold
25,000
0.32% 42
2024
Q1
$1.72M Buy
+25,000
New +$1.69M 0.28% 45

Other funds holding AXNX

Summit Securities Group's AXNX Position: Q3 2024 in Review

Summit Securities Group sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2024, closing a stake of 9,700 shares — an estimated $652K sold.

Summit Securities Group first reported a position in AXNX in Q2 2024 and held it in 1 quarter. The position peaked at $652K in Q2 2024. 233 funds tracked by Wall St. Rank hold AXNX as of Q3 2024.

  • Summit Securities Group reported no remaining Axonics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Summit Securities Group sold 9,700 Axonics, Inc. Common Stock shares in Q3 2024, an estimated $652K.
  • Summit Securities Group first reported a position in Axonics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Summit Securities Group's Axonics, Inc. Common Stock position peaked at $652K in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2024.

Based on Summit Securities Group's 13F filing for Q3 2024, filed 7 Nov 2024.